SVB Securities Stock Recommendations and Price Targets

This is a list of recent ratings by SVB Securities.

Date	Company Name	Action	Current Price	Price Target	Rating
8/15/2023	DMRA Damora Therapeutics, Inc. Common Stock	Downgrade	$29.00		Outperform ➝ Market Perform
8/15/2023	DSGN Design Therapeutics	Downgrade	$12.00	$6.00	Outperform ➝ Market Perform
8/15/2023	CYTK Cytokinetics	Initiated Coverage	$77.00	$58.00	Outperform
8/8/2023	RLAY Relay Therapeutics	Initiated Coverage	$19.00		Outperform
8/8/2023	QTRX Quanterix	Upgrade	$3.00	$30.00	Market Perform ➝ Outperform
8/8/2023	EXEL Exelixis	Initiated Coverage	$53.00	$18.00	Market Perform
8/8/2023	IDYA IDEAYA Biosciences	Initiated Coverage	$36.00	$33.00	Outperform
8/8/2023	NUVL Nuvalent	Initiated Coverage	$124.00	$42.00	Market Perform
8/4/2023	NVCR NovoCure	Initiated Coverage	$15.00	$51.00	Outperform